<?xml version="1.0" encoding="UTF-8"?>
<ref id="B55-pharmaceuticals-13-00303">
 <label>55.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lee</surname>
    <given-names>S.Y.</given-names>
   </name>
   <name>
    <surname>Ju</surname>
    <given-names>M.K.</given-names>
   </name>
   <name>
    <surname>Jeon</surname>
    <given-names>H.M.</given-names>
   </name>
   <name>
    <surname>Jeong</surname>
    <given-names>E.K.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>Y.J.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>C.H.</given-names>
   </name>
   <name>
    <surname>Park</surname>
    <given-names>H.G.</given-names>
   </name>
   <name>
    <surname>Han</surname>
    <given-names>S.I.</given-names>
   </name>
   <name>
    <surname>Kang</surname>
    <given-names>H.S.</given-names>
   </name>
  </person-group>
  <article-title>Regulation of Tumor Progression by Programmed Necrosis</article-title>
  <source>Oxid. Med. Cell. Longev.</source>
  <year>2018</year>
  <volume>2018</volume>
  <fpage>1</fpage>
  <lpage>28</lpage>
  <pub-id pub-id-type="doi">10.1155/2018/3537471</pub-id>
  <?supplied-pmid 29636841?>
  <pub-id pub-id-type="pmid">29636841</pub-id>
 </element-citation>
</ref>
